Position in CLRB
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$148,315
+$14,260 QoQ
Shares Held
53,351
+1.1% QoQ
Ownership
0.564%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 29 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLRB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,764,044 across 520 Biotechnology names. CLRB ranks #419 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CLRB
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $148,315 | 53,351 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $134,055 | 52,778 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $84,476 | 28,636 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $139,395 | 24,892 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $102,660 | 14,439 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $141,895 | 443,424 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $105,264 | 350,885 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $754,246 | 352,452 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $852,963 | 341,186 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $1,258,014 | 316,084 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $190,769 | 68,870 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $165,918 | 62,848 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $91,394 | 46,869 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $67,557 | 47,243 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $82,126 | 48,027 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $149,315 | 44,439 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $177,765 | 444,415 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $304,899 | 441,883 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $291,642 | 441,883 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $410,951 | 441,883 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $472,632 | 397,170 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $393,471 | 244,392 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $275,381 | 132,395 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||